RecruitingNCT06723951

QUALAS Validation in Dutch

Validation of the Quality of Life Assessment in Spina Bifida for Children and Adolescents in Dutch


Sponsor

Erasmus Medical Center

Enrollment

300 participants

Start Date

Dec 9, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Rationale Patients with spina bifida often experience a decreased quality of life compared to patients without spina bifida. The Quality of Life Assessment for Spina Bifida (QUALAS) is a validated questionnaire to assess the quality of life in children, teenagers and adults with spina bifida, accounting for specific factors, such as bladder and bowel dysfunction. This questionnaire enables us to assess the current spina bifida related quality of life and identify if bladder and bowel dysfunction is of influence. Objective(s) To validate the Quality of Life Assessment for Spina Bifida in Children, Teenagers and Adults in Dutch. Study type A multicenter prospective validation cohort study. Study population Children aged 8 - 17 years and adults who are diagnosed with spina bifida. As a control group children aged 8 - 17 years and adults without spina bifida will be approached at the Ear-Nose-Throat (ENT) and paediatric clinics. Methods The main study parameter is the validation of the Dutch version of the questionnaire. Patients with spina bifida are asked to fill out the QUALAS at two time-points. They are also asked to fill out an extra questionnaire at two time-points, in order to validate the QUALAS. Children and adults in the control groups are asked to fill out the two questionnaires only once. Burden and risks No (extra) outpatient visit is required. The questions in the questionnaires are similar to the medical history during an outpatient visit. The burden is therefore minimal for these patients. Participation in this study will not influence patient treatment. Recruitment and consent Parents of children and children and adults who meet the inclusion criteria and none of the exclusion criteria will be informed orally about this study by their treating urologist during a regular visit. A patient information and consent form will be handed over to the parents and children over eight years of age and adults. Parents of children and children and adults at the ENT clinic will be approached by the local urologist for participation for this study. If they are willing to participate they will be asked to sign informed consent and fill out the questionnaire.


Eligibility

Min Age: 8 Years

Inclusion Criteria14

  • Patient group:
  • Male or female patients aged 8 -12 years (QUALAS-C)
  • Male or female patients aged 13 - 17 years (QUALAS-T)
  • Adult patients (QUALAS-A)
  • Has spina bifida
  • Adult or child and at least one parent fluent in the Dutch language
  • Signed informed consent
  • Control group:
  • Male or female children aged 8 -12 years (QUALAS-C)
  • Male or female adolescents aged 13 - 17 years (QUALAS-T)
  • Adults (QUALAS-A)
  • Has no spina bifida
  • Adult or child and at least one parent fluent in the Dutch language
  • Signed informed consent

Exclusion Criteria2

  • Has a neurogenic disease other than spina bifida
  • Has had surgery in the last month

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQUALAS survey

Participants will be asked to complete the surveys at one (controls) and two (patients) timepoints.


Locations(2)

UMCG

Groningen, Netherlands

Erasmus MC

Rotterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06723951


Related Trials